We created knock-in mice in which a deletion of 3 base pairs coding for K210 in cardiac troponin (cTn)T found in familial dilated cardiomyopathy patients was introduced into endogenous genes. Membrane-permeabilized cardiac muscle fibers from mutant mice showed significantly lower Ca 2ϩ sensitivity in force generation than those from wild-type mice. Peak amplitude of Ca 2ϩ transient in cardiomyocytes was increased in mutant mice, and maximum isometric force produced by intact cardiac muscle fibers of mutant mice was not significantly different from that of wild-type mice, suggesting that Ca 2ϩ transient was augmented to compensate for decreased myofilament Ca 2ϩ sensitivity. Nevertheless, mutant mice developed marked cardiac enlargement, heart failure, and frequent sudden death recapitulating the phenotypes of dilated cardiomyopathy patients, indicating that global functional defect of the heart attributable to decreased myofilament Ca 2ϩ sensitivity could not be fully compensated by only increasing the intracellular Ca 2ϩ transient. We found that a positive inotropic agent, pimobendan, which directly increases myofilament Ca 2ϩ sensitivity, had profound effects of preventing cardiac enlargement, heart failure, and sudden death. These results verify the hypothesis that Ca 2ϩ desensitization of cardiac myofilament is the absolute cause of the pathogenesis of dilated cardiomyopathy associated with this mutation and strongly suggest that Ca 2ϩ sensitizers are beneficial for the treatment of dilated cardiomyopathy patients affected by sarcomeric regulatory protein mutations. (Circ Res.  2007;101:185-194.) 
D ilated cardiomyopathy (DCM) is a disorder of cardiac muscle characterized by cardiac enlargement and systolic dysfunction and accounts for more than 10 000 deaths annually by heart failure and sudden death in the United States. [1] [2] [3] DCM is known to result from nongenetic insults, such as viruses, alcohol, toxins, and immunologic injury; however, recent genetic studies have revealed that mutations in genes for cytoskeletal (dystrophin, desmin, ␦-sarcoglycan), nuclear envelope (tafazzin and lamin A/C), and sarcomeric (cardiac actin, ␤-cardiac myosin heavy chain, ␣-tropomyosin, cardiac myosin-binding protein C, titin/connectin, cardiac troponin [cTn]T, cTnI, and cTnC) proteins are important causes of DCM, 4 and the incidence of the inherited DCM is thought to be 20% to 35%. [5] [6] [7] Cardiac muscle contraction is regulated through Ca 2ϩ binding to cardiac troponin complex localized on the thin filaments, 8 and DCM-causing mutations in troponin complex are associated with a malignant phenotype with a high incidence of premature cardiac death and heart transplantation. 9 Cardiac troponin complex consists of 3 components of distinct structure and function, cTnT, cTnI, and cTnC. cTnT has a structural role in anchoring troponin complex to the thin filaments through its binding to tropomyosin, cTnI inhibits the interaction of myosin crossbridges with the thin filament at low Ca 2ϩ concentration, and cTnC relieves the inhibitory action of cTnI on the thin filaments on Ca 2ϩ binding. In a previous in vitro reconstitution experiment, selective displacement of endogenous cTnT in rabbit membrane-permeabilized (skinned) cardiac muscle fibers with human cTnT with a DCM-causing deletion mutation ⌬K210 was found to decrease the Ca 2ϩ sensitivity of force generation, in direct opposition to Ca 2ϩ sensitization caused by mutations associated with hypertrophic cardiomyopathy. 10 This study led us to propose that decreased Ca 2ϩ sensitivity of cardiac myofilaments might be a primary functional defect triggering the pathogenesis of DCM associated with the deletion mutation ⌬K210 in cTnT.
To test this hypothesis in vivo and to determine the exact cause of the pathogenesis of DCM associated with the deletion mutation ⌬K210 in cTnT, in the present study, we created mutant mice in which this mutation was just knocked in to the endogenous mouse TNNT2 gene using embryonic stem cell technology. Analyses of these knock-in mice demonstrated that decreased myofilament Ca 2ϩ sensitivity is the absolute cause of DCM associated with the mutation ⌬K210 in cTnT and also suggested that Ca 2ϩ sensitizers, such as pimobendan, might be beneficial for the treatment of DCM patients affected by sarcomeric regulatory protein mutations.
Materials and Methods
An expanded Materials and Methods section is available in the online data supplement at http://circres.ahajournals.org.
Generation of a Knock-In Mouse Model by Gene Targeting
Gene targeting was performed using a targeting vector including a 13.8-kb cTnT gene fragment with the loxP-neo cassette 11 on intron 12 and a deletion of 3 base pairs coding for K210 on exon 13. After germline transmission of the properly targeted ES cell clone, knock-in mice were obtained by crossing with a Cre transgenic mouse strain. 12 The experimental protocol was reviewed by the Committee of Ethics on Animal Experiments in the Faculty of Medicine, Kyushu University, and performed in accordance with the Guideline for Animal Experiments of the Faculty of Medicine, Kyushu University, and the law (No. 105) and notification (No. 6) of the Japanese Government.
Preparation of Skinned Cardiac Muscle Fibers and Force Measurements
A small fiber (Ϸ200 m in diameter) was dissected from the skinned left ventricular papillary muscle, and isometric force was measured as described previously. 13
Preparation of Intact Cardiac Muscle Fibers and Force Measurements
The left ventricular papillary muscle was mounted horizontally in a thermostatically controlled chamber, and isometric force evoked by a bipolar electrical field stimulation was measured with a semiconductor strain gauge.
Fura-2 Loading and Simultaneous Measurements of Fluorescence and Sarcomere Length
Cardiomyocytes were loaded with fura-2 acetoxymethyl ester, and contraction was evoked by bipolar electrical field stimulation. [Ca 2ϩ ] i Figure 1 . Gene-targeting strategy for creating knock-in a mouse with a deletion mutation ⌬K210 in cTnT. The targeting vector harbors a floxed neomycin resistance gene (neo) in intron 12 and a ⌬K210 mutation ‫)ء(‬ in exon 13. Gene targeting was performed in embryonic stem cells using neo and diphtheria toxin A gene (DT-A) as positive and negative selection markers, respectively. After germline transmission of the properly targeted clone (a neo-⌬K210 strain), neo was removed by crossing with a Creexpressing transgenic mouse strain to create a ⌬K210 mouse strain. Lower left, Southern blot analysis of genomic DNA from wild-type (WT), neo-⌬K210 (ϩ/neo-⌬K210), and ⌬K210 (ϩ/⌬K210) mouse strains. BspHI-digested DNAs were hybridized with a 5Ј probe. Lower right, PCR-mediated genotyping of wild-type, TNNT2 ϩ/neo-⌬K210 , and TNNT2 ϩ/⌬K210 mice. Product lengths are 0.45, 0.76, and 0.52 kb for wild-type, neo-⌬K210, and ⌬K210 alleles, respectively. and sarcomere length were simultaneously monitored using a fluorescence and contractility recording system (IonOptix) as described previously. 14
Results
We created knock-in mice in which 3 base pairs coding for the amino acid residue K210 in cTnT were deleted from their endogenous gene TNNT2 using gene-targeting technology ( Figure 1 ). These knock-in mice have the same genomic gene condition as DCM patients affected by the deletion mutation ⌬K210 in cTnT. Consistent with the previous study showing that this mutation in cTnT has a Ca 2ϩ -desensitizing effect on cardiac myofilaments in vitro, 10 skinned cardiac muscle fibers prepared from mutant mice showed a decrease in Ca 2ϩ sensitivity of force generation, as was evident from a rightward shift of the force/pCa relationship ( Figure 2A ). The pCa value at half-maximal force generation (pCa 50 , index of Ca 2ϩ sensitivity) was statistically significantly lower in mutant mice than in wild-type mice, being smaller in homozygotes (TNNT2 ⌬K210/⌬K210 ) than in heterozygotes (TNNT2 ϩ/⌬K210 ) (Fig-ure 2B ). On the other hand, the maximum force-generating capabilities ( Figure 2C ) and Hill coefficient values (an indicator of cooperativity or steepness of curve) (data not shown) were not significantly different between wild-type and mutant mice. Phosphorylation levels of cTnI at Ser22/23, known to influence myofilament Ca 2ϩ sensitivity, were also not significantly different between wild-type and mutant mice ( Figure 2D ). No significant differences in the phosphorylation levels of serine and threonine residues in cTnI and cTnT, which were reported to affect the myofilament activation level and/or Ca 2ϩ sensitivity, 15 were detected between wildtype and mutant mice by using anti-phosphoserine and anti-phosphothreonine antibodies (data not shown). These results demonstrate that the deletion mutation ⌬K210 in cTnT in vivo does have a Ca 2ϩ -desensitizing effect on force generation in cardiac muscle without changing the maximum force-generating capability and cooperativity, confirming the results of previous in vitro reconstitution studies. 10, 16, 17 It should be noted that the phosphorylation levels of cTnI and cTnT in skinned fibers could not reflect these levels in vivo, Figure 2 . Mechanical properties of skinned cardiac muscle fibers. A, Force-pCa relationships in skinned cardiac muscle fibers prepared from hearts of wild-type (WT) (E; 2 to 9 months old; nϭ16), TNNT2 ϩ/⌬K210 (F; 2 to 9 months old; nϭ16), and TNNT2 ⌬K210/⌬K210 (f; 2 to 3 months old; nϭ5) mice. B, Ca 2ϩ sensitivities (pCa 50 ) of force-pCa relationships in skinned cardiac muscle fibers. C, Maximum force-generating capabilities of skinned cardiac muscle fibers. D, Phosphorylation levels of cTnI in skinned cardiac muscle fibers. Data represent the meansϮSE for 3 fibers from different mice. Statistical significance was determined by ANOVA followed by post hoc Tukey's multiple comparison test. because skinned fibers were prepared and stored without denaturalization in ATP-containing relaxing solution, mimicking the intracellular environment. Further thorough analysis is necessary to reach a conclusion regarding alterations in sarcomeric protein phosphorylation in vivo.
The decreased Ca 2ϩ sensitivity of cardiac myofilament in knock-in mice is expected to lead to some reduction in the maximum force-generating capability of intact cardiac muscle; however, intact cardiac muscle fibers from mutant mice showed no significant decrease in maximum isometric force Hearts were excised from 6-week-old anesthetized wild-type (WT) mice and from 5-week-old TNNT2 ϩ/⌬K210 and 4-week-old TNNT2 ⌬K210/⌬K210 mice immediately after sudden death and fixed in a 10% formalin neutral-buffered solution. Fixed hearts were cut transversely at the mid-ventricular level, embedded in paraffin, sectioned at 5 m and stained with either hematoxylin and eosin or azan; connective tissues were stained blue with azan. B, Apoptosis in the left ventricular myocardium from 8-week-old mice. Apoptotic nucleus (arrow) was visualized as a dark blue precipitate by using a commercial kit for in situ detection of apoptosis in cardiac tissue sections (CardioTACS, Trevigen Inc) (top). Tissues were counterstained with Nuclear Fast Red. The number of apoptotic cardiomyocytes was normalized to the total number of cardiomyocytes in a cardiac section (bottom). Data represent the meansϮSE for 5 cardiac sections from different mice. F test indicates that the variances of the number of apoptotic cardiomyocytes in wild-type and mutant mice are significantly different (PϽ0.05), strongly suggesting that the ⌬K210 mutation has an effect on cardiomyocyte apoptosis. C, Cardiac outputs from isolated work-performing hearts of 8-week-old wild-type and mutant mice. F test indicates that the variances of cardiac outputs of wild-type and mutant mice are significantly different (PϽ0.0001), strongly suggesting that the ⌬K210 mutation has an effect on cardiac pump function. Data represent the meansϮSE of 7 hearts. D, Kaplan-Meier survival curves for wild-type (nϭ97), TNNT2 ϩ/⌬K210 (nϭ84), and TNNT2 ⌬K210/⌬K210 (nϭ47) mice. The logrank test demonstrates statistically significant differences among the 3 survival curves (PϽ0.0001). E, Telemetric ECG recording from a TNNT2 ⌬K210/⌬K210 mouse just before sudden cardiac death. TdP indicates Torsade de Pointes; VF, ventricular fibrillation. F, Protein expression level of ␤-MyHC in left ventricular myocardium. Data represent the meansϮSE for 3 mice. Statistical significance was determined by ANOVA followed by post hoc Tukey's multiple comparison test at 2 months old and unpaired T test at 3 and 5 months old.
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per cross-sectional area compared with those from wild-type mice ( Figure 3A and 3B). Intact cardiac muscle fibers from TNNT2 ⌬K210/⌬K210 mice showed slightly higher rates of isometric force development and relaxation, as was evident from a decrease in the time to peak and a steeper rise and fall in force ( Figure 3B ). Figure 3C shows Ca 2ϩ transients measured in fura-2-loaded cardiomyocytes. The peak amplitude was found to be significantly increased in mutant mice compared with wild-type mice, being greater in TNNT2 ⌬K210/⌬K210 than in TNNT2 ϩ/⌬K210 mice ( Figure 3D ). The peak rates of increase and decrease in cytoplasmic Ca 2ϩ in mutant mice are faster than those in wild-type mice, consistent with the faster kinetics of isometric force development and relaxation observed in TNNT2 ⌬K210/⌬K210 mice. Resting sarcomere length of cardiomyocytes in mutant mice was significantly longer than that in wild-type mice, consistent with decreased myofilament Ca 2ϩ sensitivity ( Figure 3E and 3F). No significant differences were observed in the number and shape of mitochondria in cardiomyocytes between wild-type and mutant mice, strongly suggesting that the change in peak amplitude of the Ca 2ϩ transient was not caused by the altered distribution of Ca 2ϩ among intracellular compartments (Figure I in the online data supplement). These findings indicate that the Ca 2ϩ transient of cardiomyocytes was augmented in mutant mice, probably to compensate for decreased myofilament Ca 2ϩ sensitivity and maintain the force-generating capability of cardiac muscle; however, fractional sarcomere shortening and peak velocity of sarcomere shortening of isolated cardiomyocytes were significantly decreased in TNNT2 ⌬K210/⌬K210 mice, indicating that a defect of dynamic contractile performance was still present in cardiomyocytes of these mutant mice ( Figure 3F ). Sarcoplasmic reticulum Ca 2ϩ content assessed by caffeine-induced Ca 2ϩ release was significantly increased in mutant mice, suggesting that sarcoplasmic reticulum Ca 2ϩ pump (SERCA2a) activity was enhanced in mutant mice (supplemental Figure II) . Whereas protein expression levels of ryanodine receptor, sarcoplasmic reticulum Ca 2ϩ pump, and phospholamban (PLB) were not significantly different between wild-type and mutant mice, significant increases in the phosphorylation of ryanodine receptor and PLB catalyzed by cAMP-dependent protein kinase were observed in TNNT2 ⌬K210/⌬K210 mice, suggesting that an increase in the intracellular cAMP level might be responsible for the augmented Ca 2ϩ transient in mutant mice (supplemental Figure III) . Despite preserved maximum isometric force-generating capability in intact cardiac muscle, knock-in mice developed markedly enlarged hearts characteristic of DCM in a mutantgene dosage-dependent manner, and histological examination of their cardiac sections showed significant interstitial fibrosis with normal cellular organization ( Figure 4A ). Cardiomyocyte apoptosis was significantly increased in the mutant mice, suggesting that apoptosis-inducing stress such as ischemia occurs in the myocardium of mutant mice ( Figure 4B ). Echocardiography demonstrated that left ventricular end-diastolic dimension was significantly increased in mutant mice, and left ventricular ejection fraction, an index of cardiac systolic function, was significantly reduced in mutant mice, with TNNT2 ⌬K210/⌬K210 being more severely affected than TNNT2 ϩ/⌬K210 (Table 1) . No significant differences were detected in ventricular wall thickness (interventricular septal thickness and left ventricular posterior wall thickness), heart rate, and blood pressure between wild-type and mutant mice ( Table 1 ). There were no significant differences in in vivo basal hemodynamic parameters between wild-type and mutant mice, but left ventricular end-systolic pressure of TNNT2 ⌬K210/⌬K210 mice was significantly lower than that of wild-type mice after administration of isoproterenol (Table 2) . Ex vivo analyses of isolated work-performing heart preparations showed that cardiac pump function was impaired in mutant mice ( Figure 4C) . These results indicate that the deletion mutation ⌬K210 in cTnT causes cardiac enlargement with marked ventricular dilation and systolic dysfunction in mice, closely recapitulating the phenotypes of human DCM patients. 18, 19 Mutant mice showed high mortality in a mutant-gene, dosagedependent manner ( Figure 4D ). TNNT2 ⌬K210/⌬K210 mice showed a particularly high incidence of sudden death in their growth periods from 1 to 3 months old. Surface ECG showed that TNNT2 ⌬K210/⌬K210 mice commonly had electrophysiological abnormality in the heart with long QT, which might be involved in their frequent sudden death (Table 1) . Telemetric ECG recordings showed that mice died by abruptly developing repetitive Torsade de Pointes several hours before death, which ultimately degenerated into ventricular fibrillation ( Figure 4E ).
The expression of ␤-cardiac myosin heavy chain (␤-MyHC) isoform in ventricular myocardium, known to be upregulated in heart failure, 20 -22 was found to be markedly increased in TNNT2 ⌬K210/⌬K210 mice at 2 months old ( Figure 4F ). A significant increase in the expression of ␤-MyHC was also detected in TNNT2 ϩ/⌬K210 mice at 3 and 5 months old but not at 2 months old, indicating that mutant mice undergo heart failure, with homozygous mice being affected from much earlier stages of life.
Oral administration of pimobendan, a Ca 2ϩ sensitizer, known to directly increase the Ca 2ϩ sensitivity of myofilament, was found to reduce the heart size of mutant mice, as was evident from a statistically significant decrease in the heart to body weight ratio ( Table 3 ). Echocardiography showed that pimobendan also improved left ventricular systolic function while reducing the left ventricular end-diastolic dimension ( Table 3 ). The expression of ␤-MyHC polypeptide isoform in ventricular myocardium was also markedly decreased in mice treated with pimobendan ( Figure 5A ).
Oral administration of pimobendan (30 mg/kg per day) was also found to markedly improve the life span of TNNT2 ⌬K210/⌬K210 mice ( Figure 5B ). Pimobendan is a socalled inodilator with inhibitory action on phosphodiesterase 3 as well as Ca 2ϩ -sensitizing action on cardiac myofilaments. 23 Oral administration of a specific phosphodiesterase 3 inhibitor amrinone had no effect on the survival of TNNT2 ⌬K210/⌬K210 mice at 30 mg/kg per day and markedly increased the mortality of TNNT2 ⌬K210/⌬K210 mice at 100 mg/kg per day ( Figure 5C ); amrinone had no direct effect on the Ca 2ϩ sensitivity of force generation in skinned cardiac muscle fibers (supplemental Figure IV) . Echocardiography and blood pressure measurements indicated that amrinone had a weaker positive inotropic effect and a stronger vasodilating effect on TNNT2 ⌬K210/⌬K210 mice compared with pimobendan ( Figure  5D ). Amrinone also had a much stronger effect on the phosphorylation of PLB catalyzed by cAMP-dependent protein kinase ( Figure 5E ). These results strongly suggest that pimobendan exerts its preventive effects on cardiac enlargement, heart failure, and sudden death as a Ca 2ϩ sensitizer. Intraperitoneal administration of ␤-adrenergic agonist isoproterenol or antagonist propranolol increased the mortality of TNNT2 ⌬K210/⌬K210 mice even at a low dose (supplemental Figure V) . The dramatic preventive effects of pimobendan on the development of pathology in TNNT2 ⌬K210/⌬K210 mice provide strong evidence that decreased myofilament Ca 2ϩ sensitivity is the absolute cause of the pathogenesis of DCM associated with the mutation ⌬K210 in cTnT and suggest that Ca 2ϩ sensitizers that antagonize the decrease in Ca 2ϩ sensitivity of cardiac myofilaments are potential therapeutic drugs. Cardiomyocytes isolated from pimobendan-treated TNNT2 ⌬K210/⌬K210 mice no longer showed enhancement of the Ca 2ϩ transient, indicating that pharmacological intervention with pimobendan can prevent or reverse functional remodeling involving the enhancement of intracellular Ca 2ϩ handling (supplemental Figure VIA) . Cardiomyocytes of pimobendan-treated TNNT2 ⌬K210/⌬K210 mice still had a defect of dynamic contractile performance (supplemental Figure VIB) , and intact cardiac muscle fibers prepared from pimobendantreated mice developed significantly lower isometric force than those from wild-type mice (supplemental Figure VIC) . Skinned cardiac muscle fibers from pimobendan-treated mice still had decreased Ca 2ϩ sensitivity of force generation, indicating that pharmacological intervention with pimobendan cannot remove the intrinsic defect from myofilaments (supplemental Figure VII) . 

Discussion
The deletion mutation ⌬K210 in the TNNT2 gene has so far been identified in 4 unrelated families. 9, 18, 19 In a family reported by Kamisago et al, 18 this mutation caused frequent sudden death in patients with mild heart failure before 30 years of age, including 2 infants and 3 young adults. In another family reported by Kamisago et al, 18 this mutation caused frequent death attributable to congestive heart failure in young patients before 20 years of age, including 2 girls (17 and 19 years old), with marked dilation of ventricles and increased interstitial fibrosis and a boy (15 years old) with a markedly enlarged heart (Ϸ400g). Early-onset phenotype with a high incidence of sudden death and/or heart failure was also reported in a family reported by Hanson et al. 19 In a family with 4 affected individuals reported by Mogensen et al, 9 3 patients died or underwent cardiac transplantation in their second or third decade of life; a patient with mild heart failure died suddenly at 36 years, a patient died of heart failure at 26 years, and a patient with very severe heart failure underwent cardiac transplantation at 22 years (weight of the explanted heart, Ͼ450 g). The knock-in mice developed enlarged hearts and heart failure and showed a high incidence of premature sudden death, closely recapitulating the clinical phenotypes of human patients; however, it should be noted that this mutation in knock-in mice causes a mutant-gene, dosagedependent phenotype of DCM. This finding indicates that the DCM phenotype caused by the deletion mutation ⌬K210 in cTnT is inherited in a semidominant, additive manner, at least in mice, but not only in a true dominant manner, as implied by a limited number of human DCM patients, which strongly suggests that homozygous patients would exhibit a more severe phenotype than heterozygous patients. Skinned cardiac muscle fibers prepared from mutant mice showed a significant decrease in the Ca 2ϩ sensitivity of force generation with no change in maximum force-generating capa-bility. Because intact cardiac muscle is known to be never activated beyond the half-maximal level, 24 the decrease in Ca 2ϩ sensitivity is expected to cause a reduction in the force generation of the myocardium even if there is no change in the maximum force-generating capability; however, intact cardiac muscle fibers showed no significant reduction in isometric force generated per cross-sectional area. Analyses using a Ca 2ϩ indicator, fura-2, revealed a significant increase in the peak amplitude of Ca 2ϩ transient in cardiomyocytes of mutant mice, which could account for the preserved isometric force-generating capability of intact cardiac muscle fibers. Despite the preserved isometric force-generating capability of intact cardiac muscle fibers, mutant mice developed marked cardiac enlargement, heart failure, and frequent sudden death, strongly suggesting that global functional defect of the heart caused by decreased myofilament Ca 2ϩ sensitivity could not be fully compensated by augmentation of the Ca 2ϩ transient. In this regard, it should be noted that the 2 isoforms of MyHC can produce a similar level of isometric force, but ␤-MyHC produces much lower power output because of its much slower sliding velocity and lower ATPase activity compared with ␣-MyHC. 25, 26 Therefore, the power output should be much lower in the myocardium of mutant mice, with ␤-MyHC isoform expression being significantly increased ( Figure 4C) , consistent with the reduced dynamic contractile performance of cardiomyocytes in TNNT2 ⌬K210/⌬K210 mice ( Figure 3F ). Our hypothesis is that reduced power output of myocardium caused by decreased myofilament Ca 2ϩ sensitivity leads to an augmentation of Ca 2ϩ transient as a compensatory response, but an increase in intracellular Ca 2ϩ will increase energy consumption through activating Ca 2ϩ -dependent metabolic processes such as the Ca 2ϩ uptake of sarcoplasmic reticulum and cellular hypertrophic response, which in turn would induce the expression of ␤-MyHC to save energy consumption. Therefore, the myocardium should repeat this compensatory response involving the augmentation of Ca 2ϩ , or vehicle only (methylcellulose, nϭ6) was administered to TNNT2 ⌬K210/⌬K210 mice orally once daily. D, Comparison of effects of pimobendan and amrinone on ejection fraction and blood pressure of TNNT2 ⌬K210/⌬K210 mice. Pimobendan (30 mg/kg, nϭ6; 100 mg/kg, nϭ5), amrinone (30 mg/kg, nϭ4; 100 mg/kg, nϭ3) or vehicle only (methylcellulose, nϭ3) was administered to 5-to 8-week-old TNNT2 ⌬K210/⌬K210 mice orally, and ejection fraction (EF) and systolic blood pressure (SBP) were measured 2 to 3 hours later. Data represent the meansϮSE. E, Comparison of effects of pimobendan and amrinone on PLB phosphorylation in the left ventricular myocardium from 5-to 8-week-old TNNT2 ⌬K210/⌬K210 mice. Immunoblot analysis was performed with anti-PLB monoclonal antibody (Abcam) and anti-phospho-PLB-Ser16 polyclonal antibody (Abcam) to obtain relative phosphorylation levels of PLB. Data represent the meansϮSE (nϭ4). Statistical significance was determined by ANOVA followed by post hoc Tukey's multiple comparison test in D and E. *PϽ0.05, **PϽ0.01, ***PϽ0.001. transient to offset the reduced power output of myocardium until it decompensates.
Mutant mice showed a high incidence of death, and two-thirds of TNNT2 ⌬K210/⌬K210 mice did not survive to 3 months of age ( Figure 4D ). In most cases, they died suddenly, without showing overt congestive heart failure symptoms, such as decreased spontaneous movement activity and dyspnea, to at least a day before their death. Instantaneous death was frequently observed by mild chest compression, suggesting that their hearts are very susceptible to fatal arrhythmias caused by mechanical stimuli. Preliminary experiments suggest that cardiomyocytes of mutant mice have a longer action potential duration and greater tendency to develop early afterdepolarization than wild-type mice, which might be responsible for their frequent sudden death (data not shown). Further studies are required to clarify the molecular mechanisms of sudden death, probably involving electrophysiological abnormality of the heart.
Finally, pimobendan had marked effects of preventing cardiac enlargement, heart failure, and sudden death of TNNT2 ⌬K210/⌬K210 mice exhibiting a particularly malignant phenotype. The results demonstrate that decreased myofilament Ca 2ϩ sensitivity is the absolute causal functional defect triggering the pathogenesis of DCM associated with the mutation ⌬K210 in cTnT and suggest that Ca 2ϩ sensitizers, such as pimobendan, might be beneficial for the treatment of DCM patients affected by mutations of the sarcomeric regulatory proteins troponin and ␣-tropomyosin, which have been demonstrated to have a common functional consequence of decreasing myofilament Ca 2ϩ sensitivity in vitro. 10, 16, 17, 27 The present study also demonstrated that cardiac myofilament Ca 2ϩ sensitivity, and thus its primary regulator, troponin complex, has an extremely important role in maintaining the physiological structure and function of the heart.
